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Abstract 
Thanks to recent advances in sequencing technology, researchers are rapidly 
accumulating vast numbers of genomic sequences for countless plant and animal species. 
However in many cases, little is known regarding the functional significance of any observed 
sequence differences. The goal of this work is to understand how two sister species of nematode 
worms have evolved genomic functional and regulatory differences, despite the high degree of 
similarity between their anatomy and life history traits. C. elegans is a model organism widely 
used in the field of molecular genetics. In C. elegans, there are four genes known to influence the 
morphology of the egg-laying structure (vulva) such that single loss-of-function mutations can 
result in the formation of a multivulval phenotype. The genome of C. briggsae, a sister species to 
C. elegans, has been less thoroughly studied. 
 
 
 In this study, eight mutant strains of C. briggsae possessing the multivulval phenotype 
have been isolated from a mutagenesis screen. Each strain has been tested against the others 
using complementation, in order to determine whether the multivulval trait results from 
mutations within the same gene or represents distinct genes. Current results suggest that 
mutations in at least seven unique genes have been isolated.  Thus the number of genes that can 
easily mutate to the multivulval phenotype in C. briggsae is larger than that found in C. elegans. 
Currently, each mutation is in the process of being „mapped‟ on the genome, meaning its 
approximate location on one of the six chromosomes is being determined using molecular 
methods. After the mapping process is completed, each mutation can be sequenced for further 
analysis.  This will confirm which of the C. briggsae strains bear mutations in one of the four 
genes identified in C. elegans, and which represent different loci previously unknown to 
influence C. briggsae vulval morphology.  
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Introduction 
C. elegans and C. briggsae are androdioecious species, meaning they have a rare 
reproductive system characterized by populations both of males and of hermaphrodites. The 
hermaphroditic animals breed with the males but are also capable of self-crossing, and will do so 
if kept in isolation. The worms have five somatic chromosomes. Males have a single X 
chromosome, whereas hermaphrodites have two X chromosomes. The hermaphrodites possess 
an egg-laying structure called the vulva. The vulva is formed from six vulval precursor cells 
(VPCs) located on the ventral side of the animal, three of which will undergo cell divisions in the 
wild-type animals. The adjacent anchor cell (AC) helps to direct organogenesis by producing 
signaling molecules such as epidermal growth factor (EGF). The EGF molecule is a ligand that 
attaches to receptors on the precursor cells triggering a cascade of reactions involved in cell 
division. Multivulval phenotypes may result from genetic disruption of the EGF gene resulting in 
overexpression, or from interference with any element of the downstream molecular pathway. 
Multivulval animals are easily distinguishable from their wild-type counterparts under a 
compound microscope. Only one of the three or four egg-laying structures will develop 
normally, forming a tube of cells connected internally to the egg-producing gonad. The others 
will appear as obvious protrusions on the animal‟s ventral side.  
Figure 3 shows the cell fates of precursor cells in wild-type animals as compared to those of 
vulvaless and multivulval individuals. The solid-colored cells will not undergo cell division, 
while shaded cells will continue to divide. 
 
 
             
             
             
             
             
       
  
The proximal cause of multivulval phenotype is excess inappropriate cell division. This 
pattern relates closely to the development of cancerous growths, which are also the result of 
uncontrolled cell division. By studying how genetic changes affect the molecular pathways 
involved in the organogenesis of the egg-laying system, we inform our understanding of the 
mechanisms of malignant tumor formation.    
AC 
      
      
      
wild-type 
vulvaless 
multivulval 
Figure 3 
The underlying genetic basis for the development of the multivulval phenotype in C. 
elegans is well understood, and the molecular pathways and networks that mediate vulval 
organogenesis have been thoroughly studied. Though the two species are morphologically and 
developmentally similar, the genetic regulations involved in C. briggsae multivulval mutants are 
unknown. Detailed comparison of the two can help us understand the evolution of complex 
regulatory networks. 
Methods 
In 2010 Steven Billups conducted a mutagenesis screen using a laboratory strain of C. 
briggsae designated AF16. Animals were exposed to the mutagen ethane methyl sulfonate 
(EMS) (Sulston and Hodgkin). EMS induces single point-mutations in DNA, usually in the form 
of a transition. A transition mutation is the exchange of one purine for another or one pyrimidine 
for another; adenine guanine or cytosine thymine. Following exposure to EMS, single 
hermaphrodites are isolated and allowed to-self cross for two generations. In the F2 generation, 
¼ of the offspring will be homozygous for any recessive genetic mutations induced by EMS. 
Since the mutations are phenotypically obvious, mutant animals can be identified and selected 
using a dissection microscope. From the screen it was possible to isolate a total of eight strains of 
C. briggsae animals characterized by mutant multivulval phenotypes. 
 Complementation Tests 
After recovering the eight mutant strains of C. briggsae characterized by a multivulval 
phenotype, the first step was to determine whether all eight mutations were unique. In C. 
elegans, a single loss-of-function mutation is known to be sufficient to produce the multivulval 
phenotype in only four genes, pry-1, lin-31, lin-13, and lin-1(Ferguson et al 1987; Jacobs et al). 
Other genes in C. elegans produce the multivulval phenotype only on conjunction with one 
another; these are known as syn-muv genes. These syn-muv genes function to restrict production 
of EGF, which is overexpressed in their absence (Andersen). There may be other relevant genes 
involved in C. briggsae, but we expected that at least some of the eight mutations occurred 
within homologues of the abovementioned four genes, and that less than eight total genes were 
involved. 
 Ideally, a cross could be done between a male homozygous for one multivulval mutation 
and a hermaphrodite homozygous for another. Unfortunately, the male multivulval animals are 
unlikely to mate; reproduction in these mutants occurs almost exclusively via self-crossing by 
the hermaphrodites. Instead a two-step process is required: first, a wild-type male is crossed with 
a hermaphrodite that is homozygous for a multivulval mutation. The heterozygous males that 
result from the cross are then crossed with a female that is homozygous for a different 
multivulval mutation, and also for a “dumpy” mutation that results in a distinct slug-like 
phenotype. This recessive “dumpy” dpy- mutation is used to identify any offspring that are the 
result of hermaphroditic self-crossing. Offspring fathered by the male will have one wild-type 
allele dpy+ and will not exhibit the dumpy phenotype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Of these offspring from the second cross, 50% will be heterozygous for multivulval 
mutations, meaning they have one wild-type allele from the male parent (muv+). These animals 
will have the wild-type phenotype. The other 50% will have two different multivulval mutations 
(muv1- and muv2-). If these occur within two different genes, the animal will have a wild-type 
phenotype. But if the mutations are in the same gene, the animal is effectively homozygous for 
the mutation, and will display the multivulval phenotype. This is what we mean by a failure to 
complement. 
Mapping the Mutations 
Having used the complementation tests to narrow down the number of genes in question, 
we next hoped to determine the locus of each mutation. C. briggsae has five somatic 
chromosomes and one X chromosome. Sex is determined by an XO system, males having only 
the five somatic chromosomes plus one X while hermaphrodites have two X chromosomes. 
None of the multivulval mutations behave as if they are sex-linked. In order to establish in what 
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general region of the chromosome each mutation is located, a series of mapping experiments was 
performed.  
 The mutations were initially induced in wild-type animals of the AF16 strain. HK104 is 
another wild-type strain, with over 30,000 identified regions that are polymorphic with respect to 
AF16 (Koboldt et al). Animals of the two strains are morphologically and developmentally 
identical. HK104 males were crossed with AF16 hermaphrodites that were homozygous for a 
multivulval mutation. These offspring were then allowed to self-cross, and from the F2 
generation a set of multivulval and a set of non-multivulval animals were isolated. For the 
chromosome that contains the mutation, the multivulval set will be enriched for the AF16 
background, while the non-multivulval set will be slightly enriched for HK104. Because there 
are many small polymorphic regions between the HK104 and AF16 strains, it is possible to 
amplify short regions of DNA harvested from the            
multivulval and non-multivulval sets, and by             
comparing the two determine whether there is             
enrichment for the AF16 background in the             
multivulval animals. A large set of primers have            
been developed by Dr. Daniel Koboldt for this                 
purpose. Figure 5 shows the PCR products of                  
a mapping experiment showing X3a to be linked                
to a region near the center of chromosome II. 
 
 
 
 Sequencing 
 Following the tentative identification of the loci responsible for each strain‟s mutation, 
candidate genes in the area in question can be amplified using a PCR reaction and sequenced. 
Genes are amplified with nested primers specifically designed for each gene. A fraction of the 
PCR sample is run on a 1% agarose gel to check for amplification of a product of the desired 
size. If the product failed to amplify, a second internal or “nested” set of primers can be used to 
amplify the products present in the first PCR reaction. This technique can sometimes enhance the 
concentration of the desired product beyond what is possible using a single reaction.  
 After the product is visually confirmed on a gel the remainder of the sample is purified by 
running it on an agarose gel and excising the band of DNA, which is then purified on a column 
using a standard Qiagen kit. Amounts of DNA in the final sample are quantified using a 
spectrophotometer and appropriate dilutions of the sample and accompanying primers are 
delivered to Ohio State‟s Plant-Microbe Genomics Facility for sequencing. The sequencing data 
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are later downloaded and saved as .ape files to be compared to the known C. briggsae sequences 
available at wormbase.org. Sequences are visually compared using the program Sequencher to 
search for mutations such as point mutations in the form of transitions or transversions, or single-
base-pair deletions. We predict the presence of such a mutation within an exon of the gene 
identified by the mapping experiments to be associated with the multivulval strain in question.   
 
Results 
  hermaphrodite muv/muv-   dpy/dpy          
male  
muv-
/muv+ 
gu102 
(B16b) 
gu167 
(Q2b) 
gu138  
(S3a) 
gu137 
(S8a) 
gu162 
(X3a) 
gu163 
(X13a) 
gu168 
(AA7b) 
gu198 
(AC18a) 
gu102 
(B16b) 0.38 0.00 0.00 nd 0.00 0.00 0.24 0.00 
gu167 
(Q2b) 0.00 0.27 0.05 nd nd 0.00 0.00 0.00 
gu138 
(S3a) 0.00 0.00 nd nd 0.52 0.00 0.00 nd 
gu137 
(S8a) nd nd nd nd 0.00 nd 0.00 0.00 
gu162 
(X3a) 0.22 0.00 0.47 nd 0.30 0.29 nd nd 
gu163 
(X13a) nd 0.00 0.00 nd 0.00 nd 0.00 nd 
gu168 
(AA7b) nd nd 0.00 nd 0.00 nd 0.38 nd 
gu198 
(AC18a) 0.00 0.02 0.01 nd 0.00 nd 0.00 nd 
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Figure 6 shows a table of the results from the complementation tests. Some are still in 
progress, and marked „nd‟ for „not determined‟. Note that no crosses into gu137 hermaphrodites 
have been performed because it has not been possible to create a strain that is homozygous both 
for the gu137 mutation and for the dumpy mutation, evidence that suggests the two may be 
linked. The numbers represent the proportion of the F2 animals that displayed the multivulval 
phenotype, where N>=25. On average, 50% of the F2 animals are expected to have inherited a 
wild-type allele from the male and be phenotypically wild-type. The two cells marked in red 
indicate crosses that failed to complement, strongly suggesting that gu162 and gu138 are allelic 
mutations in the same gene. The cell in bold indicates another failure to complement, gu102 into 
gu168, that has not been contradicted. Only 24% of the F2 animals exhibited the multivulval 
phenotype, less than the expected 50%. This may be the result of differential growth and survival 
rates between wild-type and multivulval animals. Results of the gu168 into gu102 cross are not 
yet complete. Crosses of gu162 into gu102 and gu163 also produced low levels of multivulval 
offspring, at 22% and 29% respectively. However we do not believe these results to be indicative 
of an actual failure to complement, as neither reverse cross gu102 into gu162 or gu163 into 
gu162 produced any multivulval offspring.  
The most conclusive preliminary results from the mapping experiments are shown in 
figure 7 below. (See appendix for details of the complete mapping data). In C. elegans, single 
point mutations in genes pry-1, lin-31, lin-13, and lin-1 are all sufficient to produce the 
multivulval phenotype. Mutations in axl-1 and lin-15b produce the multivulval phenotype only 
in conjunction with mutations in other genes. Figure 7 shows in green the locations of the 
homologues of genes associated with multivulval phenotypes in C. elegans. We have high 
confidence of the location of the mutant alleles listed in red- i.e. the results have proven to be 
repeatable. The mutations in black are suspected, but the evidence for their position is less 
strong. Currently we are in the early stages of sequencing some of the candidate loci in hopes of 
pinpointing the exact location and nature of the mutations. 
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Discussion 
 Based on the results of the complementation tests, we believe that at least six and 
possibly seven of the eight multivulval C. briggsae strains resulted from mutations in genes that 
are independent and distinct from one another. At least two of the multivulval alleles, gu138 and 
gu162, exhibit a failure to complement and are likely the products of mutations within the same 
gene. It is yet to be determined whether gu102 and gu168 consistently fail to complement, but 
preliminary data suggests that this may be the case. As single mutations in only four genes in the 
C. briggsae sister species C. elegans are sufficient to yield a multivulval phenotype it is possible 
that this mapping experiment may result in the discovery of additional genes in C. briggsae 
previously unknown to influence vulval organogenesis. 
 Tentative locations of seven of the eight multivulval alleles have been determined using 
standard gene mapping methods. It has not been possible to map the gu137 strain as we have 
been unable to construct a muv-/muv-;dpy/dpy line according to the usual protocol. This is likely 
the result of linkage between the two, suggesting the gu137 muv- allele and the dpy allele are 
located in close proximity to one another on a chromosome. Rather than map the gu137 mutation 
directly, we are attempting to map the dpy mutation itself in order to narrow down the 
approximate location of both mutations. Currently candidate genes in six of the eight multivulval 
strains are being amplified and sequenced for analysis: lin-13 in gu167; lin-31 in gu138 and 
gu162; lin-1 in gu102 and gu168; and pry-1 in gu198. Pending complete sequence data we will 
analyze the DNA to determine if and where the mutations of interest have occurred.  
 Understanding the genetic basis for the development of the multivulval phenotype is the 
first step in understanding the evolution of the complex molecular networks involved in vulval 
organogenesis. The phenotype results from inappropriate excess cell division, a process that 
parallels the development of malignant tumors. Some cancerous cells are known to be influenced 
by mutations to EGF pathways, especially those activating EGFR to cause overexpression, just 
as VPCs can begin to divide improperly in an environment containing high levels of transcription 
factor EGF (Zhang et al). Research of this type is critical to aid our understanding of how genetic 
changes act to regulate molecular pathways and development. 
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Appendix 
Mapping Data 
Table 1: gu102 (B16b); gu167 (Q2b); gu163 (X13a); gu138 (S3a) 
DNA prep 1 (2.3.11) 
Chr. # 
Position 
(cM) # Linkage? No Linkage PCR Gel 
1 0.7 bhp-19 B16b Q2b;X13a;S3a 2.28.11 3.1.11 
    bhp-19 B16b Q2b;X13a;S3a 3.30.11 4.1.11 
1 29.2 bhp-1 none B16b;Q2b;X13a;S3a 2.28.11 3.1.11 
1 ~52 bhp-29 Q2B B16B;Q2B;X13A 3.1.11 3.7.11 
2 ~10 bhp-2 ___ Q2b(?);X13a(?);S3a(?) 2.22.11 3.1.11 
2 23.3-28.6 bhp-21 S3a B16b;Q2b;X13a 2.8.11 2.9.11 
2 49.9 bhp-8 none B16b;Q2b;X13a;S3a 2.15.11 2.17.11 
3 12.5 bhp-14 X13a B16b;Q2b;S3a 2.4.11 2.7.11 
3 30 bhp-40 Q2b B16b;X13a;S3a 2.8.11 2.9.11 
4 1.9-5.1 bhp-13 Q2b;X13a B16b;S3a 2.17.11 2.18.11 
4 20.6 bhp-11         
4 31 bhp-9 X13a B16b;Q2b;S3a 2.15.11 2.17.11 
4 43.5 bhp-16         
4 57.8 bhp-30 ___ ? 2.17.11 2.18.11 
5 2.5-3.2 bhp-31 X13a B16b;Q2b;S3a 2.18.11 2.21.11 
5 26.7 bhp-5 ___  ? 2.18.11 2.21.11 
5 56.9 bhp-24 none B16b;Q2b;X13a;S3a 2.21.11 2.22.11 
X 8.4 bhp-25 ___ ? 2.21.11 2.22.11 
X 21-21.7 bhp-26 ___ S3a 2.22.11 3.1.11 
 
 
 
 
 
 
 
 
 
Table 2:  gu102 (B16b); gu167 (Q2b); gu163 (X13a); gu138 (S3a) 
DNA prep 2 (2.8.11) 
Chr. 
# 
Position 
(cM) # Linkage? No Linkage PCR Gel 
1 0.7 bhp-19 X13a B16b;Q2b;S3a 3.7.11 3.8.11 
 1 .7  bhp-19 X13a B16b;Q2b;S3a 3.30.11 4.1.11 
1 29.2 bhp-1 none B16b;Q2b;X13a;S3a 3.14.11 3.16.11 
1 ~52 bhp-29 none B16b;Q2b;X13a;S3a 3.8.11 3.10.11 
2 ~10 bhp-2 ___   3.11.11 3.14.11 
2 ~25 bhp-21 S3a B16b;Q2b;X13a 3.11.11 3.14.11 
2 49.9 bhp-8 none B16b;Q2b;X13a 3.28.11 3.30.11 
3 12.5 bhp-14 none B16b;Q2b;X13a;S3a 3.16.11 3.28.11 
3 30 bhp-40 Q2b? B16b;X13a;Q2b 3.7.11 3.8.11 
4 1.9-5.1 bhp-13 Q2b? X13a? B16b;S3a 3.8.11 3.10.11 
4 20.6 bhp-11 ___ ____ 3.10.11 3.11.11 
 4 20.6  bhp-11 ___ ____ 3.29.11 3.31.11 
4 31 bhp-9 Q2b;X13a;B16b? S3a 3.16.11 3.28.11 
4 43.5 bhp-16 ___ ____ 3.10.11 3.11.11 
 4 43.5  bhp-16 none B16b;Q2b;X13a;S3a 3.29.11 3.31.11 
4 57.8 bhp-30         
5 2.5-3.2 bhp-31 none B16b;Q2b;X13a;S3a 3.14.11 3.16.11 
5 26.7 bhp-5         
5 56.9 bhp-24 X13a B16b;Q2b;S3a 3.28.11 3.30.11 
X 8.4 bhp-25         
X 21-21.7 bhp-26         
 
 
 
 
 
 
 
 
 
 
Table 3:  gu162 (X3a); gu168 (AA7b); gu198 (AC18a) 
DNA prep 1 (2.8.11) 
Chr. # Position (cM) # Linkage? No Linkage PCR Gel 
1 0.7 bhp-19 AC18a X3a;AA7b 4.4.11 4.6.11 
1 29.2 bhp-1 none X3a;AA7b;AC18a 3.31.11 4.4.11 
1 ~52 bhp-29 none X3a;AA7b;AC18a 3.31.11 4.4.11 
2 ~10 bhp-2         
2 23.3-28.6 bhp-21 X3a AA7b;AC18a 4.4.11 4.6.11 
2 49.9 bhp-8 none X3a;AA7b;AC18a 4.7.11 4.8.11 
3 12.5 bhp-14 none X3a;AA7b;AC18a 4.7.11 4.8.11 
3 30 bhp-40 none X3a;AA7b;AC18a 4.5.11 4.7.11 
4 1.9-5.1 bhp-13         
4 20.6 bhp-11         
4 31 bhp-9         
4 43.5 bhp-16 none X3a;AA7b;AC18a 4.5.11 4.7.11 
4 57.8 bhp-30         
5 2.5-3.2 bhp-31 none X3a;AA7b;AC18a 4.11.11 4.12.11 
5 26.7 bhp-5         
5 56.9 bhp-24 none X3a;AA7b;AC18a 4.11.11 4.12.11 
X 8.4 bhp-25         
X 21-21.7 bhp-26         
 
 
 
 
 
 
 
 
 
 
 
 
Table 4: e9a (dumpy mutation) 
DNA prep 1 (4.11.11) 
Chr. # Position (cM) # Linkage? PCR Gel Notes 
1 0.7 bhp-19 no 4.13.11 4.14.11   
1 29.2 bhp-1 no 4.26.11 4.27.11   
1 ~52 bhp-29 no 4.13.11 4.14.11   
2 ~10 bhp-2 no 4.28.11 5.4.11   
2 ~10 bhp-33   5.13.11     
2 23.3-28.6 bhp-21 no 4.13.11 4.14.11   
2 49.9 bhp-8 no 4.13.11 4.14.11   
3 0 bhp-18   5.13.11     
3 12.5 bhp-14 no 4.13.11 4.14.11   
3 16-17 bhp-38   5.13.11     
3 21.2 bhp-12   5.13.11     
3 21.8 bhp-34   5.13.11     
3 30 bhp-40 ? 4.15.11 4.18.11 fail to amplify 
4 1.9-5.1 bhp-13 ? 4.15.11 4.18.11 fail to amplify 
4 7.9 bhp-15   5.13.11     
4 20.6 bhp-11 ? 4.28.11 5.4.11 fail to amplify 
4 31 bhp-9 no 4.15.11 4.18.11   
4 43.5 bhp-16 ? 4.26.11 4.27.11 fail to amplify 
4 57.8 bhp-30         
5 2.5-3.2 bhp-31 no 4.20.11 4.25.11 pos controls fail 
5 26.7 bhp-5 no 4.20.11 4.25.11 pos controls fail 
5 56.9 bhp-24 no 4.20.11 4.25.11 pos controls fail 
X 8.4 bhp-25         
X 21-21.7 bhp-26         
 
 
 
  
 
 
 
